• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA (CVD) TRIFECTA GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA (CVD) TRIFECTA GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TFGT-23A
Device Problems Backflow (1064); Improper Flow or Infusion (2954); Material Split, Cut or Torn (4008)
Patient Problems Heart Failure (2206); Regurgitation, Valvular (2335)
Event Date 10/19/2020
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.If returned, investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2017, a 23mm trifecta gt valve was implanted with the non-everting mattress suture technique in the patient's aortic position in which severe calcification on the annulus had occurred.An abbott sizer was used in the surgery.There was no problem observed on the echocardiogram and no cardiac murmur in the follow-up on (b)(6) 2020.However, sudden heart failure occurred in the early (b)(6) 2020 and the patient was hospitalized.Aortic regurgitation due to a leaflet tear was confirmed on the echocardiogram.On (b)(6) 2020, the trifecta gt was explanted and a competitor's valve was successfully implanted.The patient status was reported as unknown.
 
Manufacturer Narrative
Correction: h6 - device code.Explant was reported due to regurgitation and a leaflet tear.The investigation found that all three leaflets contained calcifications and tears.No inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.This was inclusive of a review of the manufacturing videos, which contained no evidence of anomalies during functional inspection.The cause of the tear could not be conclusively determined; however, the calcifications in the tissue had the potential to induce increased stress on adjacent leaflets and create an unbalanced stress relief distribution between all leaflets during coaptation, leading to leaflet tears and reduced durability.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA (CVD)
parque industrial, zona franca coyol s.a
edificio #44b, calle 0, avenida 2, coyol
alajuela 1897- 4050
CS  1897-4050
MDR Report Key10848398
MDR Text Key216831772
Report Number3008452825-2020-00644
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/26/2018
Device Model NumberTFGT-23A
Device Lot Number5728352
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/19/2020
Was the Report Sent to FDA? No
Date Manufacturer Received12/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age87 YR
-
-